Skip to main content
. 2019 Jan 19;20(2):429. doi: 10.3390/ijms20020429

Figure 2.

Figure 2

Cell cycle progression analysis in human mesothelioma cells with WT, mutated BAP1 (AD) treated with either 0.1 µM gemcitabine or with DMSO that was used as vehicle (CTRL) for 48 h, carried out using FACS). Statistical analysis is described in Materials and Methods section. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.